Adhesive structure for medical device

Information

  • Patent Grant
  • 10071198
  • Patent Number
    10,071,198
  • Date Filed
    Friday, November 2, 2012
    12 years ago
  • Date Issued
    Tuesday, September 11, 2018
    6 years ago
Abstract
A variable flexibility adhesive system may adhere a surface of a medical infusion device to the skin of a user. The system may be configured to hold a location on the surface stationary with respect to a site on the user's skin. The system may include an adhesive substrate for adhering to the user and an interface where the substrate is held to the surface of the device. The interface may totally and/or partially surround the stationary location. A skirt of the substrate may totally and/or partially surround the interface. Parts of the skirt may be stiffened. Optional features may include tabs for activation of the adhesive and/or a location for peeling the infuser away from the skin. Additionally or alternatively, the interface may have variable flexibility. Additionally or alternatively, the stiffener may include a plastic layer.
Description
BACKGROUND OF THE INVENTION

The present invention, in some embodiments thereof, relates to a method and system for attaching a device to a pliable surface and, more particularly, but not exclusively, to a method and system to attach a medical device to skin using a partially attached, variable stiffness adhesive system.


U.S. Pat. No. 6,585,707 to Cabiri discloses a system adapted to be disposed between a rigid or semi-rigid device and human skin for reliably attaching the device to the skin for an extended period of time. The system of Cabiri '707 includes a skin-contacting surface for adhering to human skin, and an opposed surface for attachment to a rigid or semi-rigid device. The system is attached along its opposed surface to a portion of the total area of the adjacent surface of the device. When the device is subjected to external stress, the stress is transmitted through the area of attachment and distributed to the unattached area. This minimizes stress on the skin and reduces the chance of detachment from the skin.


United States Patent Application No. 2007/0219597 discloses an adhesive patch system that may be used for affixing a pump or other object to a human body. Such an adhesive patch system may include two sets of adhesive members, each member including an adhesive material on at least one side so as to attach to the body. The members of the first set are spaced to allow the members of the second set to attach to the body in spaces provided between the members of the first set, and the members of the second set are spaced to allow members of the first set to detach from the body without detaching the members of the second set.


U.S. Pat. No. 8,025,658 discloses an adhesive patch of a medical device that may have selective areas with adhesive material of varying adhesion strengths. In other embodiments, an adhesive patch of a medical device may include adhesive material that may be activated by a catalyst to increase or decrease the adhesion strength of the adhesive material. In further embodiments, a medical device may include a pierceable membrane containing an agent, the pierceable membrane positioned to be pierced by a needle and to cause some of the agent to be carried to the user-patient.


U.S. Pat. No. 7,837,651 discloses a drug delivery infusion pump assembly which may include a cannula assembly comprising a cannula, which is disposable on the face of a patient, and which includes left and right cannula support wings each having a wing tip portion with an adhesive pad removably adhesively attachable to a side of the face of the patient. The adhesive pad may provide a more convenient cannula attachment for the patient than a conventional headband.


Additional background art includes adhesives for EKG electrodes and other electronic sensors having rigid and semi rigid bodies with sensing areas and or operational areas that touch or are inserted into the skin


SUMMARY OF THE INVENTION

According to an aspect of some embodiments of the present invention there is provided a system for anchoring a location on a surface of a medical infusion device to the skin of a user. The system may include an adhesive substrate for adhering to the skin of the user and an interface attaching the substrate to the surface of the device. The substrate may include a skirt extending beyond the interface. The skirt may be flexibly attached to the interface. The system may further include a stiffener stiffening a portion of the skirt. The stiffener may be less flexible than the substrate.


According to some embodiments of the invention, the stiffener may inhibit folding of the skirt under an out of plane bending force.


According to some embodiments of the invention, the out of plane bending force may include gravity.


According to some embodiments of the invention, the stiffener may be stiff enough to suspend the skirt against a gravity force.


According to some embodiments of the invention, the stiffener may be biased away from a skin attaching surface of the substrate.


According to some embodiments of the invention, the stiffener may extend the skirt away from the infusion device.


According to some embodiments of the invention, the stiffener may hold the substrate taut.


According to some embodiments of the invention, the system may further include an adhesive cover, and a tab for peeling the adhesive cover from the substrate. The stiffener may support the substrate adjacent to the tab, supplying an opposing force when peeling the cover away from the substrate.


According to some embodiments of the invention, the tab may be located on the skirt.


According to some embodiments of the invention, the stiffener may be stiff enough to resist a force on the substrate caused by peeling of the cover.


According to some embodiments of the invention, the system may further include a start location for removal of the adhesive system from the user. The stiffener may extend along a peeling line to the start location, facilitating removing of the adhesive from the user's skin.


According to some embodiments of the invention, the start location may be on the skirt.


According to some embodiments of the invention, the stiffener includes a sharp turn between the peeling line and the interface.


According to an aspect of some embodiments of the present invention there is provided a system for anchoring a medical infusion device to a skin of a recipient. The system may include an adhesive substrate configured for adhering to the skin of the user. The system may further include a location on a surface of the device to be held firmly to the skin of the user, and a multi-part adhesive cover. The system may further include a first tab for peeling a first part of the cover and a second tab for peeling a second part of the cover. The first tab may be located beside the second tab and the first tab may be separated from the second tab by a notch.


According to some embodiments of the invention, the notch may be wedge shaped.


According to some embodiments of the invention, the notch may be triangular.


According to some embodiments of the invention, the stiffener may interpose between at least a part of the surface and a remaining portion of the substrate.


According to some embodiments of the invention, the stiffener may extend beyond a boundary of the surface.


According to some embodiments of the invention, the substrate may extend beyond a boundary of the stiffener.


According to some embodiments of the invention, the substrate may be divided into a plurality of discrete portions. Each of the portions may be joined to a separate respective subsurface of the surface.


According to some embodiments of the invention, a portion of the stiffener may interpose between the interface and the substrate.


According to some embodiments of the invention, the location to be held stationary may include a needle insertion point and/or a sensor.


According to some embodiments of the invention, the interface may surround the stationary location on at least two sides.


According to some embodiments of the invention, the interface may surround the stationary location on at least three sides.


According to some embodiments of the invention, the interface may surround the stationary location completely.


According to some embodiments of the invention, the substrate may interpose between the stiffener and the interface.


According to some embodiments of the invention, the stiffener may include one or more ribs extending from the interface toward an edge of the substrate.


According to some embodiments of the invention, an unbacked section of the substrate may be surrounded on at least two sides by the stiffener.


According to some embodiments of the invention, the stiffener may be attached to the surface of the device and the substrate may be affixed to the stiffener.


According to some embodiments of the invention, an unbacked skirt of the substrate may surround the surface on at least two sides.


According to some embodiments of the invention, an unbacked skirt of the substrate may surround the surface on at least three sides.


According to some embodiments of the invention, an unbacked skirt of the substrate may surround the surface on all sides.


According to some embodiments of the invention, wherein the substrate is may not be directly attached to the surface.


According to some embodiments of the invention, the surface may be protected from inadvertent adhesion to the substrate.


According to an aspect of some embodiments of the present invention there is provided a system to remove a plurality of adhesive covers from an infusion device. The system may include a plurality of pull tabs, and at least one notch separating between two of the plurality of tabs.


According to an aspect of some embodiments of the present invention there is provided a method of installing an adhesive to a medical infusion device. The method may include attaching part of a stiffener layer to a surface of the device and affixing an adhesive substrate to the layer.


According to some embodiments of the invention, the method may further include leaving another portion of the substrate unbacked by the stiffener.


According to some embodiments of the invention, the attaching may be on at least three sides of a location to be held firmly with respect to a site on the skin of the user.


According to some embodiments of the invention, the interface may include at least one relatively flexible region at least one less flexible region.


According to an aspect of some embodiments of the present invention there is provided a system for anchoring a location on a surface of a medical infusion device to the skin of a user. The system may include a flexible adhesive substrate for adhering to the skin of the user and an interface attaching the substrate to the surface of the device. The interface may include at least one relatively flexible region and at least one less flexible region.


According to some embodiments of the invention, interface may be attached to a portion of the substrate.


According to some embodiments of the invention, the system may further include a stiffener affixed to an unattached portion of said substrate.


According to some embodiments of the invention, the system may further include an adhesive cover, and a tab for peeling the adhesive cover from the substrate. The stiffener may support the substrate adjacent to the tab, supplying an opposing force when peeling the cover away from the substrate.


According to some embodiments of the invention, the system may further include a start location for removal of the adhesive system from the user. The stiffener may extend along a peeling line to the start location, facilitating removing of the adhesive from the user's skin.


Unless otherwise defined, all technical and/or scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which the invention pertains. Although methods and materials similar or equivalent to those described herein can be used in the practice or testing of embodiments of the invention, exemplary methods and/or materials are described below. In case of conflict, the patent specification, including definitions, will control. In addition, the materials, methods, and examples are illustrative only and are not intended to be necessarily limiting.





BRIEF DESCRIPTION OF THE DRAWINGS

Some embodiments of the invention are herein described, by way of example only, with reference to the accompanying drawings. With specific reference now to the drawings in detail, it is stressed that the particulars shown are by way of example and for purposes of illustrative discussion of embodiments of the invention. In this regard, the description taken with the drawings makes apparent to those skilled in the art how embodiments of the invention may be practiced.


In the drawings:



FIG. 1 is a flow chart illustration of an exemplary embodiment of a method of adhering a medical device to a user's skin;



FIG. 2A is a view of an infuser from a first perspective showing an adhesive cover on a surface configured for attaching adjacent to a user's skin;



FIG. 2B is a is a perspective view of a infuser from a second perspective;



FIG. 3 is a cutaway projection of a stiffener layer of an adhesive system attached to an infuser;



FIG. 4A is a exploded view of an exemplary embodiment of an adhesive system;



FIG. 4B is a projection view of an exemplary embodiment of an adhesive cover;



FIG. 5A is a perspective view of an exemplary embodiment of an adhesive cover on an infuser having an attaching interface surrounding a needle insertion point;



FIG. 5B is a exploded view of an exemplary embodiment of an adhesive system for an infuser having an attaching interface surrounding a needle insertion point;



FIG. 6A is a exploded view of an exemplary embodiment of an adhesive system having discrete sections;



FIG. 6B is a schematic view through layers of an exemplary embodiment of an adhesive system having discrete sections;



FIG. 7 is a flow chart illustration of an exemplary embodiment of a method for attaching an adhesive system to an infuser.





DETAILED DESCRIPTION OF THE INVENTION
Overview

The present invention, in some embodiments thereof, relates to a method and system for adhering a device to a pliable surface and, more particularly, but not exclusively, to a method and system to adhere a medical device to skin using a variable stiffness adhesive system.


An aspect of some embodiments is that the adhesive system may optionally be configured to anchor a part of the device to a fixed site on the user's skin. In some embodiments, a location on the device surface that is intended to be anchored to the user's skin may be totally surrounded and/or surrounded on at least two and/or three side by an interface attaching the surface to the adhesive system.


An aspect of some embodiments is that the adhesive system may optionally include a skirt region extending beyond the attaching interface. Optionally, the skirt region may be configured to have variable flexibility and/or elasticity and/or absorbency and/or breathability and/or adhesion.


Some surfaces adhered rigidly against a human skin may tend to detach for a few reasons including. For example, the weight of the device applied at a center of gravity at some distance from the skin surface may tend to peel the top edge of the device away from the skin. For example, the adhesive and/or the substrate may irritate the skin by retaining moisture and/or by applying stress forces and/or by preventing access to air. Irritation may cause the skin to slough off surface cells and the adhesive adhered to them. For example, as the skin stretches and/or flexes one part of the adhesive may be leveraged against another part, tearing the device away the adhered skin. Optionally, the flexible skirt region may reduce detachment associated with rigid and/or sealed surfaces, for example for one or more of reasons numerated above.


An aspect of some embodiments is that in the skirt region, the adhesive may optionally be applied to a substrate. Optionally the substrate may be breathable and/or absorbent and/or flexible and/or elastic. Alternatively or additionally the substrate may include a foam, for example flexible foams manufactured by Kendall Polychem or and Avery Dennison. Some examples of foams include Actiflex (made by Kendall Polychem and PVC1, a PVC closed cell foam made by Avery Dennison under the model number Q527297, or be made of woven and non-woven fabrics for example 3M#1776 0.3 mm White Spunlace Polyester Nonwoven with layer Acrylate and/or, Sontara marketed by Du Pont.


An aspect of some embodiments is that some locations the skirt may optionally include a stiffener. The stiffener may include, for example, a flexible plastic layer lending support to the substrate. Optionally the stiffener may be stiffer than the adhesive substrate but flexible enough to conform to the skin of the user. Alternatively or additionally, the stiffener may include a resin applied to stiffen certain parts of the adhesive substrate. In some embodiments, the stiffener may include a rib and/or a bend.


An aspect of some embodiments is that the stiffener may optionally be made of plastic, for example Polyethylene terephthalate (PET) having a thickness that may range for example between 0.1 and 0.8 mm. Other materials may also be used include for example Polycarbonate and/or ABS.


An aspect of some embodiments is that a skirt may optionally project beyond the edge of the device. For example the skirt may project for a minimum distance ranging between 2 to 30 mm. The maximum length of the skirt beyond the edge of the device may range for example between 15 and 30 mm. Optionally, the skirt may have a maximum length at the removal point from which the adhesive is configured to be peeled from the user's skin.


Optionally, the stiffener may support the substrate from out of plane bending forces and/or extend the substrate outward. Optionally, the stiffener may be designed to prevent the adhesive substrate from folding up or sticking to itself before adhesion to the user. Alternatively or additionally, the stiffener may help stabilize the device on the user's skin.


An aspect of some embodiments is that the device may be for example an infuser. Optionally, a part of the infuser held substantially stationary with respect to a fixed point on the user's skin may include, for example a needle insertion point. Optionally, the location may be held substantially stationary in the direction perpendicular to the skin surface (the needle may remain inserted at a substantially fixed depth that may range for example between 0.3 and 7.5 mm). Alternatively and/or additionally a device may be anchored to hold a needle substantially stationary in a lateral plane. In some embodiments, the needle may be held at an insertion angle that ranges for example between 20 and 90 from plane of the skin surface. Permissible fluctuations of the insertion angle may range between ±7 degrees. In some embodiments, fluctuations in the insertion depth (along the axis of the needle) during infusion may range, for example, between 0.1 and 0.5 mm.


An aspect of some embodiments is that an adhesive system may optionally be configured to anchor a sensor to a testing site on the user's skin. For example, the device may include a skin proximity sensor. Optionally, the adhesive may anchor the device holding the proximity sensor in constant contact with the user's skin. Additionally or alternatively, the adhesive may anchor the device holding a sensor stationary with respect the user's skin (for example the sensor may be held in the range of 0-25 degrees from the plane parallel to the surface of the skin and/or the sensor may be held at a fixed distance and/or depth±1.5 mm from the surface of the user's skin).


An aspect of some embodiments is that they may optionally include a preferred removal point. Optionally, at the removal point, the adhesive system may be configured to make it easy to grasp the adhesive and peel off the user's skin. For example, the stiffener may broaden near the removal point. Optionally, the stiffener may be shaped to lead outward from the interface and then turn sharply toward the removal point. Alternatively and or additional the adhesive may be lacking and/or reduced at the removable point. Optionally, the removal point may be marked for easy recognition.


An aspect of some embodiments is that a portion of the adhesive may optionally be protected from sticking to the adjacent surface of the device. Optionally the edge of the adhesive may be protected from sticking to adjacent surface, for example, by extending the edge of the adhesive beyond the adjacent surface of the device and/or by the stiffener intervening between the edge of the adhesive and the adjacent surface of the device.


An aspect of some embodiments is that a multipart protective cover may optionally be supplied for the adhesive surface. The protective cover may include one or more tabs for peeling off respective discrete parts of the cover. Optionally the tabs may be separated by one or more notches. In some embodiments, the width of the notch may range for example between 0.1 and 1 mm. In some embodiments, the length of the notch may range for example between 15-30 mm. Optionally, the shape of the notch may depend upon the form of the tabs. For example the notch may have a wedge and/or a triangular shape. In some embodiments, the stiffener may be configured to facilitate peeling of the cover from the adhesive. For example, the stiffener may supply extra support to the substrate at the tab location. For example the stiffener may prevent the substrate from bending more than 5 degrees when the cover is peeled from the substrate.


An aspect of some embodiments is that the interface connecting the adhesive substrate to the infuser may have a variable stiffness.


Exemplary embodiments of the invention are described in terms of an infusion device. It is understood that various other devices may also use an adhesion system as described herein. Unless stated otherwise, embodiments of the current invention should include various infusion devices, and/or other devices, for example iontophoretic drug delivery systems; minimally invasive sensors, including glucose sensors; diagnostic devices such as devices used in heart rate, pulse and ECG monitoring; ostomy products; nerve stimulators; external programming, data collection and monitoring devices for pace makers and defibrillators; implantable hearing aids and the like.


In some embodiments the adhesive system may be detachable from the infusion device. In some embodiments, a needle assembly may be attached to the injector via a flexible tube. Optionally, the needle assembly may be adhered independently of the body of the user.


Before explaining at least one embodiment of the invention in detail, it is to be understood that the invention is not necessarily limited in its application to the details of construction and the arrangement of the components and/or methods set forth in the following description and/or illustrated in the drawings and/or the Examples. The invention is capable of other embodiments or of being practiced or carried out in various ways.


Method of Adhering a Device to Skin



FIG. 1 is a flow chart showing steps in adhering an infusion device to the skin of a user. Some advantageous aspects of the adhesion system of the current invention will be enumerated as they relate to each act of adhering the device.


Adhering a device may start 102, for example by activating 104 the adhesive. Activating 104 the adhesive may include for example, removing a protective cover from an adhesive. Alternatively or additionally, activation 104 may include attaching an adhesive system to the infuser and/or putting a catalyst on an adhesive substrate.


In some embodiments of the present invention, the protective cover may be made of multiple sheets each sheet covering part of the adhesive. Optionally each sheet may have a separate pull tab. The tabs of the sheets may be located one next to the other with a notch separating between tabs of different sheets. In some embodiments, the notch may make their removal of the sheets more intuitive.


In some embodiments a stiffener may help prevent the adhesive substrate from folding up. Optionally, a portion of the stiffener may be located near the location from which the protective layer is to be peeled. Optionally, the stiffener may be thicker or wider at the location from which the adhesive cover is to be peeled. For example, the stiffener may include a rib which extends to the location of a pull tab from which the protective cover is to be peeled. In some embodiments, the form of the stiffener may make it easier to peel off the protective cover. For example, the stiffener may steady the adhesive as the user pulls away the cover. Alternatively or additionally, the adhesive and the stiffener may be configured to avert the adhesive contacting and/or sticking to the surface of the infuser.


The shape of the cover may be configured such that the pull tab provides good leverage for pulling off the whole cover. Optionally, the pull tab may be located close areas of exceptionally peeling difficulty. Optionally, there may be multiple tabs to provide improved leverage to multiple areas of the cover.


In some embodiments, after removing the protective cover, the device may be adhered 106 to the skin of the user.


In some embodiments, once the infuser is adhered 106 to the user, the infuser will sense its proximity 107 to the user. For example, the infuser may include an optional proximity sensor. The proximity sensor may include, for example, a mechanical switch, an optical sensor, a heat sensor, and/or an electrical resistance sensor. Optionally, the adhesive may be configured to hold tightly to the skin of the user at the location of the proximity sensor. Optionally, the infuser and/or the adhesive may be configured to avoid the user's skin folding at the location of the proximity sensor and/or the needle insertion point.


In some embodiments, a needle may be inserted 108 into the user. Alternatively or additionally there may be a catheter and/or a needless delivery system. Optionally, at the insertion point, the infuser may be held stationary with respect to the user's skin by the adhesive. Holding the insertion point stationary may, for example, avoid the needle moving in the skin, being removed, or causing unnecessary pain.


In some embodiments, once infusion has begun, the adhesive may hold 110 the infuser stably to the user until infusion finishes. The adhesive may have optional properties that increase the stability of the adhesion. For example, the adhesive substrate may be flexible and/or stretchable, for example to reduce strain on the adhesive when the user moves. For example, the adhesive substrate may be breathable and/or absorbent, for example to reduce skin irritation and resultant sloughing. In some embodiments, the stiffener may enhance the mechanical connection between some locations on the adhesive and the infuser.


Optionally, adherence to the skin may be enhanced by the presence of a flexible adhesive skirt around the area where the adhesive is rigidly and/or semi-rigidly attached to the infuser. The weight of the infuser may be applied to the skirt region as a sheering stress rather than a peeling stress. The skirt may optionally reduce the probability that the infuser will spontaneously peel off the user.


In some embodiments, the adhesive may be supported by a flexible substrate. Optionally the substrate may have properties that improve adherence to the skin and/or reduce skin irritation. Optionally, the substrate may comply with the skin. For example the substrate may be flexible and/or elastic and/or breathable and/or absorbent. Optionally, in some locations, the substrate will be free to stretch or flex. Optionally, at some locations, the substrate will be supported by a stiffener. The stiffener may, for example make it easier to apply the adhesive to the skin and/or the stiffener may enhance the mechanical connection between the infuser and a peripheral area of the adhesive.


In some embodiments, after infusion has finished, the infuser may be removed 112 from the user. Optionally, the adhesive system may be designed to facilitate removal 112. For example, there may be an intuitive mark of a preferred removal point. For example, there may be enhancements to make it the removal location easier to grasp and/or reduce the adhesion at removal location. The geometry of the adhesive may be configured so that the removal location has good leverage for removal of a large portion of the adhered surface.


After removal 112, infusions may optionally end 114 and the infuser may optionally be disposed of, for example by throwing it into the municipal garbage and/or into medical and/or hazardous waste.


Exemplary Infuser Having a Skin Sensor Near Edge



FIGS. 2A-4C illustrate an exemplary embodiment of an infuser having a proximity sensor near the edge of the infuser. The exemplary embodiment illustrates various geometric features of the adhesive system that lend extra support to particular areas. For example, an adhesive skirt may be provided. Optionally near the sensor, the skirt may be stiffened and/or widened, for example to help hold the sensor firmly against the skin of the user. Optionally, ribs of stiffener may prevent the adhesive from folding over and sticking onto itself. Alternatively or additionally, the adhesive and/or the stiffener may be configured to make it easier to peel a cover off of the adhesive and/or to make it easier to remove the device from the user, for example, after use.



FIGS. 2A and 2B are perspective illustrations of an exemplary embodiment 220 of an infuser. The view of FIG. 2A shows the adjacent surface intended for adhesion to the user facing up, towards the viewer. In the view of FIG. 2B the adjacent surface intended for adhesion to the user faces downward, away from the viewer. FIGS. 2A and 2B illustrate exemplary external geometry of a device and the relationship between the parts.


Some embodiments may include an optional sensor, for example a mechanical skin proximity sensor 224. Optionally, sensor 224 may include a needle insertion point 226. In exemplary embodiment 220, proximity sensor 224 is located near the edge of the injector.


Optionally, for example as illustrated in FIG. 2B, a skirt of adhesive substrate 218 may extend beyond the adjacent surface. In some embodiments, a stiffener 216 may support the skirt. For example, in FIG. 2B a rib 228a supports an area 335b,c of the skirt from folding downward due to an out of plane bending force, for example gravity. For example, when the infuser is held adhesive side down, stiffener 216 may suspend the skirt. For example the skirt may bend downward to an angle of for example less than 10 degrees. Alternatively or additionally, parts of the stiffener may optionally be biased towards and/or away from the skin contact side of the adhesive. For example in FIG. 2B stiffener 216 may, for example, parts of the stiffener may be biased downward and/or upward.


Optionally, near proximity sensor 224 the skirt may be wider and/or include extra stiffener 216. In some embodiments, stiffener 216 may help hold proximity sensor 224 tightly against the skin of the user. In some embodiments, the stiffened skirt may help to avoid sensor 224 falsely registering removal of the device from the skin, for example when the user twists or moves.


In some embodiments, stiffener 216 may extend a skirt of substrate 218 away from the infuser. For example, stiffener 216 includes ribs 228a,b. Optionally, ribs 228a,b may serve for example to extend substrate 218 away from the infuser. Extending the skirt may, optionally, prevent substrate 218 from folding over onto itself, for example, before being attached to a user.


In some embodiments, sections of adhesive substrate 218 may not be backed by stiffener 216 and/or may not be attached to the surface of the injector. In some embodiments, the unbacked adhesive substrate 218 may be more flexible and/or elastic and/or breathable than the areas with backing. In the exemplary embodiment 220, for example, the edges of the skirt and some internal regions of the adhesive substrate are unbacked.


Optionally, rib 228a may widen near an edge which is to be used as a start location 234 for removal of the infuser from the user. For example, after infusion has finished a user may grasp location 234 and peel the infuser off his skin. The widening of rib 228a may, in some embodiments, may it easier to grasp the adhesive substrate to peel it off of the skin of the user. Alternatively or additionally stiffener 216 may extend beyond adhesive substrate 218 at removal location 234. Alternatively or additionally, the adhesive may be reduced, removed, and/or covered near removal location 234. In the exemplary embodiment of FIG. 2B, rib 228a runs along an edge of the skirt of substrate 218. Optionally, rib 228a is configured so that when location 234 is peeled away from the user's skin, the peeling force is distributed along a peeling line A-A′ (for example the outer edge of the rib 228a), facilitating removal of the entire adhesive system from the user's skin. Alternatively or additionally, the peeling line may be straight line and/or a curved. In some embodiments, stiffener 216 may be connected to the infuser at an interface. The path along the stiffener from the interface to the removal start location 234 may include a sharp turn 233. For example, in the exemplary embodiment of FIG. 2B, turn 233 is approximately 100 degrees. Optionally, a turn between an interface connecting the stiffener to the infuser and the removal point may range, for example, between 45 and 135 degrees.


In FIG. 2A an exemplary two part adhesive cover 222a,b is shown having two peeling tabs 242a,b. Optionally, each peeling tab 242a,b may give improved leverage to peel a corresponding part of adhesive cover 222a,b as compared to a single peeling tab. For example, tab 242b may give good leverage to remove a battery insulator 223. Peeling tabs 242a,b may, optionally, extend out from the edge of the injector to make it easier for a user to locate the peeling location. Optionally, peeling tabs 242a,b may be located one next to the other to make it easier for the user to recognize them. In some embodiments, the tabs may extend away from the edge of the infuser ranging for example between 15 mm and 30 mm.


Optionally, the geometry of the adhesive system may be configured to make peeling off the adhesive cover easier and/or more intuitive. For example, near the peeling location, the adhesive matrix may be stiffened by the stiffener and/or by an interface to the infuser



FIG. 3 illustrates a cutaway view of stiffener 216 of embodiment 220. The edge 325 of the adjacent surface of the injector is illustrated by a dashed line. In exemplary embodiment 220 stiffener 216 is attached to the adjacent surface of the infuser near proximity sensor 224 and needle insertion point 226.


Optionally, ribs 228a,b and ribs 328a,b,c may extend toward the edges of adhesive substrate 218. Optionally there may be unbacked areas 335a,b,c,d of the adhesive substrate, for example on the edges (for example unbacked area 335c,d) and/or between ribs 228a,b and ribs 328a,b and ribs (for example, unbacked areas 335a,b). In some embodiments, an unbacked area (for example areas 335a,b) may be located between the skin of a user and the adjacent surface of the infuser and/or beyond an edge 325 of the infuser (for example areas 335c,d).


In the exemplary embodiment of FIG. 3, adhesive substrate 218 is optionally configured to avoid unintentional adhesion of substrate 218 to the infuser. For example, edges of unbacked areas of substrate 218 are optionally located away from the surface of the infuser. For example, the edges of the unbacked areas 335c,d extend beyond edge 325 of the infuser surface.



FIG. 4A is an exploded view of adhesive substrate 218, stiffener 216, and an infuser/adhesive interface 430 (where adhesive substrate 218 and/or stiffener 216 are attached to the adjacent surface of the infuser). In some embodiments, interface 430 may be entirely or mainly around the needle insertion point and/or the proximity sensor. Optionally, an extension 438 of the interface 430 may attach a portion of rib 328c to the adjacent surface. Attaching a portion of ribs 328c to the adjacent surface may for example increase the rigidity of the adhesion of injection location 226 to the user. Optionally, all or some of ribs 228a,b, and/or 328a,b,c may be attached and/or unattached to the adjacent surface of the infuser. Leaving ribs 228a,b and/or 328a,b,c fully and/or partially unattached may allow adhesive substrate 218 to conform more to the skin of the user.


In some embodiments, interface 430 may not surround the proximity sensor and/or the needle insertion point (for example when the top of the proximity sensor reaches the edge 325 of the adjacent surface [as illustrated in FIG. 3] then interface 430 may have an empty space above the proximity sensor as illustrated in FIG. 4A). In some embodiments, the stiffener may be used to lend stability where the adhesive substrate is not attached to the adjacent surface of the infuser. For example, stiffener 216, fills in the empty space above the proximity sensor.


In some embodiments, part or the entire stiffener 216 may extend away from needle insertion point 226 and or proximity sensor 224. Optionally, part of the extension may be attached to the adjacent surface of the infuser, for example section of rib 328c is attached to the adjacent surface by an extension 438 of interface 430. Optionally, parts of stiffener 216 may be affixed to part of the adhesive substrate 218 but not attached to the adjacent surface of the infuser. Optionally, parts of stiffener 216 may intervene between substrate 218 and the adjacent surface of the infuser and/or may protrude out from edge 325 of the infuser.


In some embodiments, a portion of stiffener 216 may support substrate 218 adjacent to a peeling tab 242a. For example, rib 328b may supply an opposing force pulling adhesive 218 from tab 242b as cover 222b is peeled away substrate 218. In some embodiments, cover 222a,b and/or tabs 242a,b may be configured to avoid liner tear. For example, the shape may encourage pulling along a rolling line. For example a tab may be located at a sharp and/or rounded corner of the cover.



FIG. 4B illustrates an exemplary embodiment of a two part adhesive cover 422a,b that may be used, for example with exemplary infuser embodiment 220. Removal tabs 442a,b are located near a battery insulator slit 444. For example, when a user grasps removal tab 442b and pulls up, he may get good leverage to pull out a battery insulator strip attached to cover 422b and passing through slit 444. A triangle shaped notch 443 between tabs 442a,b indicates to a user that separate tabs 442a,b remove respective parts of adhesive cover 442a,b


Exemplary Interface Surrounding Proximity Sensors and/or Needle Insertion Point



FIG. 5A is a perspective view of an alternative exemplary embodiment 520 of an infuser. In embodiment a mechanical skin proximity sensor 524a and an optical skin proximity sensor 524b are located at a distance from an edge of the adjacent surface configured for connection to the skin of a user. Optionally, in embodiment 520, the needle insertion point and/or the sensor location are entirely surrounded by the interface attaching the adhesive matrix to the infuser.



FIG. 5B is an exploded view of four layers of an adhesive structure that may be used for example with embodiment 520. In some embodiments, an interface 530a,b may surround skin proximity sensors 524a,b and/or needle insertion point 526. In some embodiments part of an interface 530a may attach a stiffener 516 to an adjacent surface of an infuser and an adhesive substrate 518 to stiffener 516. Alternatively or additionally, part of the interface 530b may attach the adhesive substrate 518 directly to the adjacent surface of the infuser. In some areas, alternatively or additionally, there may be a padding layer between the adhesive substrate and the adjacent surface of the infuser.


In some embodiments stiffener 516 may be biased. For example ribs 528a,c may be biased upward 527a away from the user's skin. Alternatively or additionally, 528a,c may be biased outward 527b, extending substrate 518 and/or holding it taut. Optionally, when the infuser is held above the skin of the user, ribs 528a,c may hold the skirt of substrate 518 upwards away from the skin attaching surface, preventing it from folding downward.


In some embodiments ribs 528a,b,c,d may extend from an attached area 530a,b toward the periphery of adhesive substrate 518.



FIG. 5A shows a hypodermic needle 532 extending out of a needle insertion hole 526. A two part adhesive cover 522a,b includes respective peeling tabs 542a,b.


Options, Alternatives and Additional Aspects



FIGS. 6A and 6B show a few alternative configurations for an adhesive system. For example, single device may have a few discrete adhesive systems connected to different points on one or more surfaces adjacent to a user. Tabs for activating the various discrete adhesive systems may also be discrete and/or they may be integrated for intuitive synchronized activation. Alternatively or additionally, a stiffener may be attached to a surface of the device and the adhesive affixed to the stiffener. Alternatively or additionally, the adhesive substrate may be attached directly to a surface of the device and the stiffener affixed to part of the adhesive substrate. Alternatively or additionally, all or part of the adhesive substrate and/or the stiffener may intervene between the skin of the user and the adjacent surface of the infuser. Alternatively or additionally, all or part of the stiffener and/or the adhesive substrate may project over the edge of the surface of the infuser.


In the exemplary embodiment of FIGS. 6A and 6B, four discrete adhesive systems are illustrated attached to a single surface of a device. For example, an interface 630a may attach a portion of a stiffener 616a to a part of the adjacent surface of the infuser. Optionally, a portion of an adhesive substrate 618a may be affixed to stiffener 616a and/or attached to the interface 630a. For example adhesive substrate 618a may be have areas of different levels of attachment: an outer unbacked skirt area 635a which extends outward beyond the boundaries of both stiffener 616a and interface 630a; a stiffened flexible skirt area 635b affixed to the stiffener at a location beyond the boundaries of the interface 630a inward and/or outward; a fully attached area 635c which is a affixed to stiffener 616a at a location where stiffener 616a is attached to surface 620 via interface 630a, and an inner unbacked area 635d completely and/or partially surround by interface 630a. All or part of areas 635a,b,d may optionally be located between surface 620 and the skin of a user and/or may extend beyond the edges of adjacent surface 620 of the infuser.


In some embodiments, an adhesive substrate may be attached in all or in part directly to an adjacent surface of an infuser. For example, substrate 618b is attached directly to the surface of the infuser in interface 630b in the vicinity of needle insertion point 626. Optionally an area 635e of interface 630b near insertion point 626 may be stiff. Optionally an area 635f of interface 630b further from insertion point 626 may be relatively flexible. For example in area 635f flexible padding may intervene between the surface of the infuser and substrate 618b (in the exemplary embodiment of FIGS. 6A, B the boundary between areas 635e and 635f is marked by a dashed line). Optionally, there may be a rib of stiff interface to a peeling location on the edge of the interface. The peeling location may be for peeling the adhesive from the skin of the user and/or for peeling an adhesive cover from the adhesive.


In some embodiments, an adhesive substrate may be affixed to a flexible stiffener extending away from an interface. For example an adhesive substrate 618c is shown affixed to a portion of flexible stiffener 616c extending away from an interface 630c. In the example of FIGS. 6A, B substrate 618c is show extending beyond surface 620 of the infuser. Alternatively or additionally, a portion of an adhesive substrate may be affixed to a stiffener layer away from an attachments interface but located between the user's scan and adjacent surface of the infuser. For example, intervention of the stiffener between the matrix and the user may help prevent unintended adhesion of the substrate to the infuser.


In some embodiments, a stiffener layer may not be directly attached to the infuser. For example, stiffener 616d is not directly attached to the infuser. Stiffener 616d is affixed to adhesive substrate 618d which is attached to the infuser at interface 630d.


In some embodiments, the adhesive substrate may have a skirt partially surrounded the interface joining the adhesive to the device. For example, adhesive substrates 618c and 618d have skirts surrounding the respective interfaces 630c and 630d on only two sides. Alternatively or additionally, the skirt may surround the interface on all sides. For example, areas 335a,b,c,d surround interface 430 on all sides.


Optionally, the surface of the infuser that is adjacent to the user's skin may be shaped to facilitate placing flat against the skin. A stiffener may also optionally be designed for conforming to the skin surface during placement. Optionally, the infuser may be shaped to encourage proper placement of the device. Optionally the infuser may be designed to avoid placement of the needle insertion point and/or the skin proximity sensor near a fold in the skin of the user.


Exemplary Method of Mounting an Adhesive on an Infuser



FIG. 7 is a flow chart illustrating an exemplary method of attaching an adhesive system to an infuser. The method includes bonding various layers of the adhesive system to one another and/or to the infuser.


The method may start, for example, by attaching 774 a portion of the stiffener to a surface of the infuser. Alternatively or additionally, the stiffener may be attached to a coupling that can be removably attached to the infuser.


In some embodiments, an adhesive substrate may be affixed 778 to the stiffener. Alternatively or additionally, the adhesive substrate may be affixed directly to the infuser.


In some embodiments an adhesive surface may be covered 780 with a protective cover.


General


In some embodiments, some layers may be supplied in a prebonded state. For example, the adhesive substrate may be supplied with the adhesive cover already in place. Optionally the adhesive substrate and/or the stiffener layer may also be supplied in a precut form.


It is expected that during the life of a patent maturing from this application many relevant adhesives, substrates and stiffener materials will be developed and the scope of the terms are intended to include all such new technologies a priori. As used herein the term “about” refers to ±5%


The terms “comprises”, “comprising”, “includes”, “including”, “having” and their conjugates mean “including but not limited to”.


The term “consisting of” means “including and limited to”.


The term “consisting essentially of” means that the composition, method or structure may include additional ingredients, steps and/or parts, but only if the additional ingredients, steps and/or parts do not materially alter the basic and novel characteristics of the claimed composition, method or structure.


As used herein, the singular form “a”, “an” and “the” include plural references unless the context clearly dictates otherwise. For example, the term “a compound” or “at least one compound” may include a plurality of compounds, including mixtures thereof.


Throughout this application, various embodiments of this invention may be presented in a range format. It should be understood that the description in range format is merely for convenience and brevity and should not be construed as an inflexible limitation on the scope of the invention. Accordingly, the description of a range should be considered to have specifically disclosed all the possible subranges as well as individual numerical values within that range. For example, description of a range such as from 1 to 6 should be considered to have specifically disclosed subranges such as from 1 to 3, from 1 to 4, from 1 to 5, from 2 to 4, from 2 to 6, from 3 to 6 etc., as well as individual numbers within that range, for example, 1, 2, 3, 4, 5, and 6. This applies regardless of the breadth of the range.


Whenever a numerical range is indicated herein, it is meant to include any cited numeral (fractional or integral) within the indicated range. The phrases “ranging/ranges between” a first indicate number and a second indicate number and “ranging/ranges from” a first indicate number “to” a second indicate number are used herein interchangeably and are meant to include the first and second indicated numbers and all the fractional and integral numerals therebetween.


It is appreciated that certain features of the invention, which are, for clarity, described in the context of separate embodiments, may also be provided in combination in a single embodiment. Conversely, various features of the invention, which are, for brevity, described in the context of a single embodiment, may also be provided separately or in any suitable subcombination or as suitable in any other described embodiment of the invention. Certain features described in the context of various embodiments are not to be considered essential features of those embodiments, unless the embodiment is inoperative without those elements.


Although the invention has been described in conjunction with specific embodiments thereof, it is evident that many alternatives, modifications and variations will be apparent to those skilled in the art. Accordingly, it is intended to embrace all such alternatives, modifications and variations that fall within the spirit and broad scope of the appended claims.


All publications, patents and patent applications mentioned in this specification are herein incorporated in their entirety by reference into the specification, to the same extent as if each individual publication, patent or patent application was specifically and individually indicated to be incorporated herein by reference. In addition, citation or identification of any reference in this application shall not be construed as an admission that such reference is available as prior art to the present invention. To the extent that section headings are used, they should not be construed as necessarily limiting.

Claims
  • 1. A system for anchoring a location on a surface of a medical infusion device to a skin of a user, the system comprising: an adhesive substrate for adhering to the skin of the user;a stiffener directly covering a portion of the adhesive substrate; andan interface directly covering a portion of the stiffener, such that the stiffener is interposed between the interface and the adhesive substrate and is arranged below a horizontal plane of the interface and above a horizontal plane of the adhesive substrate, the interface attaching a portion of said adhesive substrate to the surface of the device, wherein said adhesive substrate is a separate and distinct layer from said stiffener and said interface;wherein said adhesive substrate includes a skirt extending beyond said interface, said skirt being flexibly attached to said interface; andwherein the stiffener directly covers and stiffens a portion of said skirt, said stiffener being less flexible than said substrate.
  • 2. The system of claim 1, wherein said stiffener inhibits folding of said skirt under an out of plane bending force.
  • 3. The system of claim 2, wherein said stiffener inhibits folding of said skirt due to gravity.
  • 4. The system of claim 3, wherein said stiffener suspends said skirt against a gravity force.
  • 5. The system of claim 3, wherein said stiffener is biased away from a skin attaching surface of said substrate.
  • 6. The system of claim 1, further including: an adhesive cover, anda tab for peeling said adhesive cover from said substrate and
  • 7. The system of claim 6, wherein said tab is located on said skirt.
  • 8. The system of claim 6, wherein said stiffener is stiff enough to resist a force on said substrate caused by peeling of said cover.
  • 9. The system of claim 1, further including: a start location for removal of the system from the user and wherein said stiffener extends along a peeling line to said start location, facilitating removing of said adhesive substrate from the user's skin.
  • 10. The system of claim 9, wherein said start location is on said skirt.
  • 11. The system of claim 9, wherein said stiffener includes a sharp turn between said peeling line and said interface.
  • 12. The system of claim 1, wherein said stiffener interposes between at least a part of the surface and a remaining portion of said substrate.
  • 13. The system of claim 1, wherein said stiffener extends beyond a boundary of said surface.
  • 14. The system of claim 1, wherein said substrate extends beyond a boundary of said stiffener.
  • 15. The system of claim 1, wherein said substrate, is divided into a plurality of discrete portions and wherein each of said portions is joined to a separate respective subsurface of said surface.
  • 16. The system of claim 1, wherein said interface surrounds the location on at least two sides.
  • 17. The system of claim 1, wherein said stiffener includes one or more ribs extending from said interface toward an edge of said substrate.
  • 18. The system of claim 1, wherein an unbacked section of said substrate is surrounded on at least two sides by said stiffener.
  • 19. The system of claim 1, where said stiffener is attached to the surface of the device and said substrate is affixed to said stiffener.
  • 20. The system of claim 1, wherein an unbacked skirt of said substrate surrounds the surface on at least two sides.
  • 21. The system of claim 1, wherein said substrate is not directly attached to said surface.
  • 22. A system for anchoring a location on a surface of a medical infusion device to a skin of a user the system comprising: a flexible adhesive substrate for adhering to the skin of the user;an interface attaching said adhesive substrate to the surface of the device and wherein said interface includes at least one relatively flexible region and at least one less flexible region;a stiffener directly covering a portion of the adhesive substrate, wherein the interface covers a portion of the stiffener, such that a portion of the stiffener is interposed between the interface and the adhesive substrate and is arranged below a horizontal plane of the interface and above a horizontal plane of the adhesive substrate;an adhesive cover; anda tab for peeling said adhesive cover from said adhesive substrate, wherein said adhesive substrate is a separate and distinct layer from said stiffener and said interface,wherein the stiffener is affixed to an unattached portion of said adhesive substrate, andwherein said stiffener supports said adhesive substrate adjacent to said tab, supplying an opposing force when peeling said adhesive cover away from said adhesive substrate.
  • 23. The system of claim 22, wherein said interface is attached to a portion of said adhesive substrate.
  • 24. The system of claim 22, further including: a start location for removal of the system from the user and
US Referenced Citations (524)
Number Name Date Kind
1795630 Wilson Mar 1931 A
2860635 Wilburn Nov 1958 A
3203269 Perrine Aug 1965 A
3212685 Swan et al. Oct 1965 A
3794028 Mueller et al. Feb 1974 A
3994295 Wulff Nov 1976 A
4195636 Behnke Apr 1980 A
4218724 Kaufman Aug 1980 A
4273122 Whitney et al. Jun 1981 A
4300554 Hessberg et al. Nov 1981 A
4403987 Gottinger Sep 1983 A
4435173 Siposs et al. Mar 1984 A
4465478 Sabelman et al. Aug 1984 A
4565543 Bekkering et al. Jan 1986 A
4585439 Michel Apr 1986 A
4599082 Grimard Jul 1986 A
4601702 Hudson Jul 1986 A
4685903 Cable et al. Aug 1987 A
4698055 Sealfon Oct 1987 A
4810215 Kaneko Mar 1989 A
4850966 Grau et al. Jul 1989 A
4867743 Vaillancourt Sep 1989 A
4886499 Cirelli et al. Dec 1989 A
4919596 Slate et al. Apr 1990 A
4929241 Kulli May 1990 A
4950246 Muller Aug 1990 A
D322671 Szwarc Dec 1991 S
5109850 Blanco et al. May 1992 A
5112317 Michel May 1992 A
5131816 Brown et al. Jul 1992 A
5190521 Hubbard et al. Mar 1993 A
5254096 Rondelet et al. Oct 1993 A
5300045 Plassche, Jr. Apr 1994 A
5342313 Campbell et al. Aug 1994 A
5348544 Sweeney et al. Sep 1994 A
5366498 Brannan et al. Nov 1994 A
5383865 Michel Jan 1995 A
5478315 Brothers et al. Dec 1995 A
5482446 Williamson et al. Jan 1996 A
5496274 Graves et al. Mar 1996 A
5501665 Jhuboo et al. Mar 1996 A
5505709 Funderburk et al. Apr 1996 A
5562686 Sauer et al. Oct 1996 A
5593390 Castellano et al. Jan 1997 A
5616132 Newman Apr 1997 A
5643218 Lynn et al. Jul 1997 A
5645955 Maglica Jul 1997 A
5647853 Feldmann et al. Jul 1997 A
5662678 Macklin Sep 1997 A
5672160 Osterlind et al. Sep 1997 A
5690618 Smith et al. Nov 1997 A
D393314 Meisner et al. Apr 1998 S
5766186 Faraz et al. Jun 1998 A
5795675 Maglica Aug 1998 A
5800420 Gross et al. Sep 1998 A
5807375 Gross et al. Sep 1998 A
5814020 Gross Sep 1998 A
5836920 Robertson Nov 1998 A
5848991 Gross et al. Dec 1998 A
5851197 Marano et al. Dec 1998 A
5858001 Tsals et al. Jan 1999 A
5858008 Capaccio Jan 1999 A
5868710 Battiato et al. Feb 1999 A
5931814 Alex et al. Aug 1999 A
5941850 Shah et al. Aug 1999 A
5948392 Haslwanter et al. Sep 1999 A
5954697 Srisathapat et al. Sep 1999 A
5957895 Sage et al. Sep 1999 A
5968011 Larsen et al. Oct 1999 A
5993423 Choi Nov 1999 A
6004297 Steenfeldt-Jensen et al. Dec 1999 A
6033245 Yamkovoy Mar 2000 A
6033377 Rasmussen et al. Mar 2000 A
6064797 Crittendon et al. May 2000 A
6074369 Sage et al. Jun 2000 A
6149614 Dunshee Nov 2000 A
6186982 Gross et al. Feb 2001 B1
6200289 Hochman et al. Mar 2001 B1
6200296 Dibiasi et al. Mar 2001 B1
6224569 Brimhall May 2001 B1
6248093 Moberg Jun 2001 B1
6277095 Kriesel et al. Aug 2001 B1
6277098 Klitmose et al. Aug 2001 B1
6277099 Strowe et al. Aug 2001 B1
6287283 Ljunggreen et al. Sep 2001 B1
6293925 Safabash et al. Sep 2001 B1
6302633 Poe Oct 2001 B1
6336729 Pavelle et al. Jan 2002 B1
6345968 Shupe Feb 2002 B1
6377848 Garde et al. Apr 2002 B1
6391005 Lum et al. May 2002 B1
6423029 Elsberry Jul 2002 B1
D465026 May et al. Oct 2002 S
6458102 Mann et al. Oct 2002 B1
6485461 Mason et al. Nov 2002 B1
6485465 Moberg et al. Nov 2002 B2
6500150 Gross et al. Dec 2002 B1
6503231 Prausnitz et al. Jan 2003 B1
6511336 Turek et al. Jan 2003 B1
6517517 Farrugia et al. Feb 2003 B1
D471274 Diaz et al. Mar 2003 S
D471983 Hippolyte et al. Mar 2003 S
6558351 Steil et al. May 2003 B1
6589229 Connelly et al. Jul 2003 B1
6595956 Gross et al. Jul 2003 B1
6595960 West et al. Jul 2003 B2
6645181 Lavi et al. Nov 2003 B1
6652482 Hochman Nov 2003 B2
6656158 Mahoney et al. Dec 2003 B2
6656159 Flaherty Dec 2003 B2
6659980 Moberg et al. Dec 2003 B2
6673033 Sciulli et al. Jan 2004 B1
6679862 Diaz et al. Jan 2004 B2
6689118 Alchas et al. Feb 2004 B2
6699218 Flaherty et al. Mar 2004 B2
6722916 Buccinna et al. Apr 2004 B2
6743211 Prausnitz et al. Jun 2004 B1
6749587 Flaherty Jun 2004 B2
6752787 Causey, III et al. Jun 2004 B1
6768425 Flaherty et al. Jul 2004 B2
6786890 Preuthun et al. Sep 2004 B2
6800071 McConnell et al. Oct 2004 B1
6805687 Dextradeur et al. Oct 2004 B2
6824529 Gross et al. Nov 2004 B2
6843782 Gross et al. Jan 2005 B2
6854620 Ramey Feb 2005 B2
6905298 Haring Jun 2005 B1
6908452 Diaz et al. Jun 2005 B2
6960192 Flaherty et al. Nov 2005 B1
6997727 Legrady et al. Feb 2006 B1
7001360 Veasey et al. Feb 2006 B2
7034223 Fan et al. Apr 2006 B2
7048715 Diaz et al. May 2006 B2
7060054 Nissels Jun 2006 B2
7060059 Keith et al. Jun 2006 B2
7097637 Triplett et al. Aug 2006 B2
7128727 Flaherty et al. Oct 2006 B2
7144384 Gorman et al. Dec 2006 B2
D544092 Lewis Jun 2007 S
7225694 Said Jun 2007 B2
7247149 Beyerlein Jul 2007 B2
7250037 Shermer et al. Jul 2007 B2
7267669 Staunton et al. Sep 2007 B2
7291132 DeRuntz et al. Nov 2007 B2
7291159 Schmelzeisen-Redeker et al. Nov 2007 B2
7303549 Flaherty et al. Dec 2007 B2
7344385 Chen Mar 2008 B2
7364570 Gerondale et al. Apr 2008 B2
7390314 Stutz, Jr. et al. Jun 2008 B2
7407493 Cane′ Aug 2008 B2
D578210 Muta et al. Oct 2008 S
7455663 Bikovsky Nov 2008 B2
7465290 Reilly Dec 2008 B2
7488181 van Haaster Feb 2009 B2
7497842 Diaz et al. Mar 2009 B2
7501587 English Mar 2009 B2
7503786 Kato et al. Mar 2009 B2
7530964 Lavi et al. May 2009 B2
7547281 Hayes et al. Jun 2009 B2
7565208 Harris et al. Jul 2009 B2
7569050 Moberg et al. Aug 2009 B2
D600341 Loerwald Sep 2009 S
7585287 Bresina et al. Sep 2009 B2
7588559 Aravena et al. Sep 2009 B2
7589974 Grady et al. Sep 2009 B2
D602155 Foley et al. Oct 2009 S
D602586 Foley et al. Oct 2009 S
D604835 Conley Nov 2009 S
7628770 Ethelfeld Dec 2009 B2
7628772 McConnell et al. Dec 2009 B2
7628782 Adair et al. Dec 2009 B2
7637891 Wall Dec 2009 B2
7637899 Woolston et al. Dec 2009 B2
7641649 Moberg et al. Jan 2010 B2
7660627 McNichols et al. Feb 2010 B2
7678079 Shermer et al. Mar 2010 B2
7682338 Griffin Mar 2010 B2
7686787 Moberg et al. Mar 2010 B2
7699829 Harris et al. Apr 2010 B2
7699833 Moberg et al. Apr 2010 B2
7704088 Sakamoto Apr 2010 B2
7704227 Moberg et al. Apr 2010 B2
7704229 Moberg et al. Apr 2010 B2
7704231 Pongpairochana et al. Apr 2010 B2
7708717 Estes et al. May 2010 B2
7713238 Mernoe May 2010 B2
7713240 Istoc et al. May 2010 B2
7717913 Novak et al. May 2010 B2
7722574 Toman et al. May 2010 B2
7736344 Moberg et al. Jun 2010 B2
7744589 Mounce et al. Jun 2010 B2
7749194 Edwards et al. Jul 2010 B2
7776030 Estes et al. Aug 2010 B2
7780637 Jerde et al. Aug 2010 B2
7789857 Moberg et al. Sep 2010 B2
7801599 Young et al. Sep 2010 B2
7806868 De Polo et al. Oct 2010 B2
7828528 Estes et al. Nov 2010 B2
7837659 Bush, Jr. et al. Nov 2010 B2
7846132 Gravesen et al. Dec 2010 B2
7854723 Hwang et al. Dec 2010 B2
7857131 Vedrine Dec 2010 B2
7879025 Jacobson et al. Feb 2011 B2
7918825 O'Connor et al. Apr 2011 B2
7935104 Yodfat et al. May 2011 B2
7935105 Miller et al. May 2011 B2
7938803 Mernoe et al. May 2011 B2
7955305 Moberg et al. Jun 2011 B2
7967784 Pongpairochana et al. Jun 2011 B2
7967795 Cabiri Jun 2011 B1
7981105 Adair et al. Jul 2011 B2
7988683 Adair et al. Aug 2011 B2
7993300 Nyholm et al. Aug 2011 B2
7993301 Boyd et al. Aug 2011 B2
7998111 Moberg et al. Aug 2011 B2
8021357 Tanaka et al. Sep 2011 B2
8025658 Chong et al. Sep 2011 B2
8029469 Ethelfeld Oct 2011 B2
8034019 Nair et al. Oct 2011 B2
8038666 Triplett et al. Oct 2011 B2
8057431 Woehr et al. Nov 2011 B2
8057436 Causey et al. Nov 2011 B2
8062253 Nielsen et al. Nov 2011 B2
8066694 Wagener Nov 2011 B2
D650079 Presta et al. Dec 2011 S
D650903 Kosinski et al. Dec 2011 S
8086306 Katzman et al. Dec 2011 B2
D652503 Cameron et al. Jan 2012 S
8105279 Mernoe et al. Jan 2012 B2
8114046 Covino et al. Feb 2012 B2
8114064 Alferness et al. Feb 2012 B2
8114066 Naef et al. Feb 2012 B2
D657462 Siroky Apr 2012 S
8147446 Yodfat et al. Apr 2012 B2
8152764 Istoc et al. Apr 2012 B2
8152770 Reid Apr 2012 B2
8152779 Cabiri Apr 2012 B2
8152793 Keinanen et al. Apr 2012 B2
8157693 Waksmundzki Apr 2012 B2
8162674 Cho et al. Apr 2012 B2
8162923 Adams et al. Apr 2012 B2
8167841 Teisen-Simony et al. May 2012 B2
8172591 Wertz May 2012 B2
8172804 Bikovsky May 2012 B2
8182462 Istoc et al. May 2012 B2
8197444 Bazargan et al. Jun 2012 B1
8206351 Sugimoto et al. Jun 2012 B2
8221356 Enggaard et al. Jul 2012 B2
8267921 Yodfat et al. Sep 2012 B2
8287520 Drew et al. Oct 2012 B2
8292647 McGrath et al. Oct 2012 B1
8308679 Hanson et al. Nov 2012 B2
8323250 Chong et al. Dec 2012 B2
8372039 Mernoe et al. Feb 2013 B2
8373421 Lindegger et al. Feb 2013 B2
8409142 Causey et al. Apr 2013 B2
8414557 Istoc et al. Apr 2013 B2
8430847 Mernoe et al. Apr 2013 B2
8465455 Cabiri Jun 2013 B2
8469942 Kow et al. Jun 2013 B2
8474332 Bente, IV et al. Jul 2013 B2
8475408 Mernoe et al. Jul 2013 B2
8479595 Vazquez et al. Jul 2013 B2
8495918 Bazargan et al. Jul 2013 B2
8496862 Zelkovich et al. Jul 2013 B2
8512287 Cindrich et al. Aug 2013 B2
8517987 Istoc et al. Aug 2013 B2
8523803 Favreau Sep 2013 B1
8556856 Bazargan et al. Oct 2013 B2
8562364 Lin et al. Oct 2013 B2
8574216 Istoc et al. Nov 2013 B2
8603026 Favreau Dec 2013 B2
8603027 Favreau Dec 2013 B2
8628510 Bazargan et al. Jan 2014 B2
8674288 Hanson et al. Mar 2014 B2
8679060 Mernoe et al. Mar 2014 B2
8690855 Alderete, Jr. et al. Apr 2014 B2
8708961 Field et al. Apr 2014 B2
8751237 Kubota Jun 2014 B2
8753326 Chong et al. Jun 2014 B2
8753331 Murphy Jun 2014 B2
8764707 Moberg et al. Jul 2014 B2
8764723 Chong et al. Jul 2014 B2
8771222 Kanderian, Jr. et al. Jul 2014 B2
8777896 Starkweather et al. Jul 2014 B2
8777924 Kanderian, Jr. et al. Jul 2014 B2
8777925 Patton Jul 2014 B2
8784369 Starkweather et al. Jul 2014 B2
8784370 Lebel et al. Jul 2014 B2
8790295 Sigg et al. Jul 2014 B1
8795224 Starkweather et al. Aug 2014 B2
8795231 Chong et al. Aug 2014 B2
8795260 Drew Aug 2014 B2
8801668 Ali et al. Aug 2014 B2
8801679 Iio et al. Aug 2014 B2
8810394 Kalpin Aug 2014 B2
8814379 Griffiths et al. Aug 2014 B2
8920374 Bokelman et al. Dec 2014 B2
9061104 Daniel Jun 2015 B2
9061110 Avery et al. Jun 2015 B2
9089475 Fangrow Jul 2015 B2
9089641 Kavazov Jul 2015 B2
20010025168 Gross et al. Sep 2001 A1
20010041869 Causey et al. Nov 2001 A1
20020010423 Gross et al. Jan 2002 A1
20020029018 Jeffrey Mar 2002 A1
20020040208 Flaherty et al. Apr 2002 A1
20020055711 Lavi et al. May 2002 A1
20020065488 Suzuki et al. May 2002 A1
20020107487 Preuthun Aug 2002 A1
20020123740 Flaherty et al. Sep 2002 A1
20020161332 Ramey Oct 2002 A1
20020169215 Meng Nov 2002 A1
20030009133 Ramey Jan 2003 A1
20030125671 Aramata et al. Jul 2003 A1
20030135159 Daily et al. Jul 2003 A1
20030160683 Blomquist Aug 2003 A1
20030171717 Farrugia et al. Sep 2003 A1
20040010207 Flaherty et al. Jan 2004 A1
20040092873 Moberg May 2004 A1
20040116866 Gorman et al. Jun 2004 A1
20040127857 Shemesh et al. Jul 2004 A1
20040158172 Hancock Aug 2004 A1
20040186419 Cho Sep 2004 A1
20040260233 Garibotto et al. Dec 2004 A1
20050033234 Sadowski et al. Feb 2005 A1
20050065466 Vedrine Mar 2005 A1
20050065472 Cindrich et al. Mar 2005 A1
20050071487 Lu et al. Mar 2005 A1
20050113761 Faust et al. May 2005 A1
20050159706 Wilkinson et al. Jul 2005 A1
20050171476 Judson et al. Aug 2005 A1
20050171512 Flaherty Aug 2005 A1
20050177136 Miller Aug 2005 A1
20050197650 Sugimoto et al. Sep 2005 A1
20050203461 Flaherty et al. Sep 2005 A1
20050238507 Dilanni et al. Oct 2005 A1
20050283114 Bresina et al. Dec 2005 A1
20060013716 Nason et al. Jan 2006 A1
20060030816 Zubry Feb 2006 A1
20060095014 Ethelfeld May 2006 A1
20060122577 Poulsen et al. Jun 2006 A1
20060173406 Hayes et al. Aug 2006 A1
20060173439 Thorne et al. Aug 2006 A1
20060195029 Shults et al. Aug 2006 A1
20060211982 Prestrelski et al. Sep 2006 A1
20060229569 Lavi et al. Oct 2006 A1
20060264889 Moberg et al. Nov 2006 A1
20060264890 Moberg et al. Nov 2006 A1
20060264894 Moberg et al. Nov 2006 A1
20060270987 Peter Nov 2006 A1
20060283465 Nickel et al. Dec 2006 A1
20060293722 Slatkine et al. Dec 2006 A1
20070021733 Hansen et al. Jan 2007 A1
20070049865 Radmer et al. Mar 2007 A1
20070073228 Mernoe et al. Mar 2007 A1
20070118405 Campbell et al. May 2007 A1
20070123819 Mernoe et al. May 2007 A1
20070167912 Causey et al. Jul 2007 A1
20070185449 Mernoe Aug 2007 A1
20070197968 Pongpairochana et al. Aug 2007 A1
20070203454 Shermer et al. Aug 2007 A1
20070233038 Pruitt et al. Oct 2007 A1
20070282269 Carter et al. Dec 2007 A1
20080021439 Brittingham et al. Jan 2008 A1
20080033367 Haury et al. Feb 2008 A1
20080033369 Kohlbrenner et al. Feb 2008 A1
20080033393 Edwards et al. Feb 2008 A1
20080051711 Mounce et al. Feb 2008 A1
20080051730 Bikovsky Feb 2008 A1
20080059133 Edwards et al. Mar 2008 A1
20080097381 Moberg et al. Apr 2008 A1
20080108951 Jerde et al. May 2008 A1
20080140006 Eskuri et al. Jun 2008 A1
20080140018 Enggaard et al. Jun 2008 A1
20080147004 Mann et al. Jun 2008 A1
20080167641 Hansen et al. Jul 2008 A1
20080188813 Miller et al. Aug 2008 A1
20080208138 Lim et al. Aug 2008 A1
20080215006 Thorkild Sep 2008 A1
20080215015 Cindrich et al. Sep 2008 A1
20080243087 Enggaard et al. Oct 2008 A1
20080249473 Rutti et al. Oct 2008 A1
20080262436 Olson Oct 2008 A1
20080269687 Chong et al. Oct 2008 A1
20080269723 Mastrototaro et al. Oct 2008 A1
20080274630 Shelton et al. Nov 2008 A1
20080294143 Tanaka et al. Nov 2008 A1
20080306449 Kristensen et al. Dec 2008 A1
20080312601 Cane Dec 2008 A1
20080319416 Yodfat et al. Dec 2008 A1
20090041805 Walker Feb 2009 A1
20090048347 Cohen et al. Feb 2009 A1
20090054750 Jennewine Feb 2009 A1
20090069784 Estes et al. Mar 2009 A1
20090076453 Mejlhede et al. Mar 2009 A1
20090088694 Carter et al. Apr 2009 A1
20090088731 Campbell et al. Apr 2009 A1
20090093792 Gross et al. Apr 2009 A1
20090093793 Gross et al. Apr 2009 A1
20090105650 Wiegel et al. Apr 2009 A1
20090124977 Jensen May 2009 A1
20090143730 De Polo et al. Jun 2009 A1
20090143735 De Polo et al. Jun 2009 A1
20090149830 Spector Jun 2009 A1
20090182277 Carter Jul 2009 A1
20090204076 Liversidge Aug 2009 A1
20090209896 Selevan Aug 2009 A1
20090234319 Marksteiner Sep 2009 A1
20090240240 Hines et al. Sep 2009 A1
20090253973 Bashan et al. Oct 2009 A1
20090259176 Yairi Oct 2009 A1
20090281585 Katzman et al. Nov 2009 A1
20090299290 Moberg Dec 2009 A1
20090299397 Ruan et al. Dec 2009 A1
20090326459 Shipway et al. Dec 2009 A1
20090326509 Muse et al. Dec 2009 A1
20100030156 Beebe et al. Feb 2010 A1
20100030198 Beebe et al. Feb 2010 A1
20100049128 McKenzie et al. Feb 2010 A1
20100049144 McConnell et al. Feb 2010 A1
20100057057 Hayter et al. Mar 2010 A1
20100076412 Rush et al. Mar 2010 A1
20100094255 Nycz et al. Apr 2010 A1
20100100076 Rush et al. Apr 2010 A1
20100100077 Rush et al. Apr 2010 A1
20100106098 Atterbury et al. Apr 2010 A1
20100121314 Iobbi May 2010 A1
20100137790 Yodfat Jun 2010 A1
20100137831 Tsals Jun 2010 A1
20100145303 Yodfat et al. Jun 2010 A1
20100145305 Alon Jun 2010 A1
20100162548 Leidig Jul 2010 A1
20100168607 Miesel Jul 2010 A1
20100168683 Cabiri Jul 2010 A1
20100198157 Gyrn et al. Aug 2010 A1
20100204657 Yodfat et al. Aug 2010 A1
20100234767 Sarstedt Sep 2010 A1
20100234805 Kaufmann et al. Sep 2010 A1
20100234830 Straessler et al. Sep 2010 A1
20100241065 Moberg et al. Sep 2010 A1
20100264931 Lindegger et al. Oct 2010 A1
20100274112 Hoss et al. Oct 2010 A1
20100274192 Mernoe Oct 2010 A1
20100280499 Yodfat et al. Nov 2010 A1
20100331826 Field et al. Dec 2010 A1
20110034900 Yodfat et al. Feb 2011 A1
20110054399 Chong et al. Mar 2011 A1
20110054400 Chong et al. Mar 2011 A1
20110066131 Cabiri Mar 2011 A1
20110125056 Merchant May 2011 A1
20110160654 Hanson et al. Jun 2011 A1
20110160666 Hanson et al. Jun 2011 A1
20110160669 Gyrn et al. Jun 2011 A1
20110172645 Moga et al. Jul 2011 A1
20110172745 Na et al. Jul 2011 A1
20110178472 Cabiri Jul 2011 A1
20110201998 Pongpairochana et al. Aug 2011 A1
20110238031 Adair et al. Sep 2011 A1
20110245773 Estes et al. Oct 2011 A1
20110270160 Mernoe Nov 2011 A1
20110282282 Lorenzen et al. Nov 2011 A1
20110282296 Harms et al. Nov 2011 A1
20110295205 Kaufmann et al. Dec 2011 A1
20110313238 Reichenbach et al. Dec 2011 A1
20110319861 Wilk Dec 2011 A1
20110319919 Curry et al. Dec 2011 A1
20120004602 Hanson et al. Jan 2012 A1
20120010594 Holt et al. Jan 2012 A1
20120022344 Kube Jan 2012 A1
20120022499 Anderson et al. Jan 2012 A1
20120029431 Hwang et al. Feb 2012 A1
20120035546 Cabiri Feb 2012 A1
20120041364 Smith Feb 2012 A1
20120041414 Estes et al. Feb 2012 A1
20120071828 Tojo et al. Mar 2012 A1
20120096953 Bente, IV et al. Apr 2012 A1
20120096954 Vazquez et al. Apr 2012 A1
20120101436 Bazargan et al. Apr 2012 A1
20120108933 Liang et al. May 2012 A1
20120129362 Hampo et al. May 2012 A1
20120160033 Kow et al. Jun 2012 A1
20120165733 Bazargan et al. Jun 2012 A1
20120165780 Bazargan et al. Jun 2012 A1
20120226234 Bazargan et al. Sep 2012 A1
20120259282 Alderete, Jr. et al. Oct 2012 A1
20130012875 Gross et al. Jan 2013 A1
20130068319 Plumptre et al. Mar 2013 A1
20130085457 Schiff et al. Apr 2013 A1
20130089992 Yang Apr 2013 A1
20130096509 Avery et al. Apr 2013 A1
20130110049 Cronenberg et al. May 2013 A1
20130133438 Kow et al. May 2013 A1
20130237953 Kow et al. Sep 2013 A1
20130245595 Kow et al. Sep 2013 A1
20130245596 Cabiri et al. Sep 2013 A1
20130253419 Favreau Sep 2013 A1
20130253420 Favreau Sep 2013 A1
20130253421 Favreau Sep 2013 A1
20130296799 Degtiar et al. Nov 2013 A1
20130304021 Cabiri et al. Nov 2013 A1
20130323699 Edwards et al. Dec 2013 A1
20130331791 Gross et al. Dec 2013 A1
20140055073 Favreau Feb 2014 A1
20140055076 Favreau Feb 2014 A1
20140058349 Bazargan et al. Feb 2014 A1
20140083517 Moia et al. Mar 2014 A1
20140094755 Bazargan et al. Apr 2014 A1
20140128807 Moberg et al. May 2014 A1
20140128835 Moberg et al. May 2014 A1
20140135692 Alderete, Jr. et al. May 2014 A1
20140135694 Moberg et al. May 2014 A1
20140142499 Moberg et al. May 2014 A1
20140148784 Anderson et al. May 2014 A1
20140148785 Moberg et al. May 2014 A1
20140163522 Alderete, Jr. et al. Jun 2014 A1
20140194819 Maule et al. Jul 2014 A1
20140194854 Tsals Jul 2014 A1
20140207064 Yavorsky Jul 2014 A1
20140207065 Yavorsky Jul 2014 A1
20140207066 Yavorsky Jul 2014 A1
20140213975 Clemente et al. Jul 2014 A1
20140236087 Alderete, Jr. et al. Aug 2014 A1
20140261758 Wlodarczyk et al. Sep 2014 A1
Foreign Referenced Citations (87)
Number Date Country
1224341 Jul 1999 CN
1747683 Mar 2006 CN
1863566 Nov 2006 CN
1929884 Mar 2007 CN
101090749 Dec 2007 CN
101460207 Jun 2009 CN
101970033 Feb 2011 CN
201941304 Aug 2011 CN
102186733 Sep 2011 CN
102256657 Nov 2011 CN
1064693 Sep 1959 DE
0017412 Oct 1980 EP
0222656 May 1987 EP
0401179 Dec 1990 EP
1530979 May 2005 EP
1666080 Jun 2006 EP
2060606 May 2009 EP
2498589 Sep 2012 EP
H07-194701 Aug 1995 JP
H09-505758 Jun 1997 JP
2001-512992 Aug 2001 JP
2002-505601 Feb 2002 JP
2002-507459 Mar 2002 JP
2002-528676 Sep 2002 JP
2003-501157 Jan 2003 JP
2003-527138 Sep 2003 JP
2003-534061 Nov 2003 JP
2004-501721 Jan 2004 JP
2004-512100 Apr 2004 JP
2005-523127 Aug 2005 JP
2005-270629 Oct 2005 JP
2007-509661 Apr 2007 JP
2008-534131 Aug 2008 JP
2008-220961 Sep 2008 JP
2009-502273 Jan 2009 JP
9009202 Aug 1990 WO
9307922 Apr 1993 WO
9407553 Apr 1994 WO
9513838 May 1995 WO
9609083 Mar 1996 WO
9632975 Oct 1996 WO
9700091 Jan 1997 WO
9710012 Mar 1997 WO
9733638 Sep 1997 WO
9857683 Dec 1998 WO
9929151 Jun 1999 WO
9959665 Nov 1999 WO
0025844 May 2000 WO
0187384 Nov 2001 WO
0189607 Nov 2001 WO
0189613 Nov 2001 WO
0202165 Jan 2002 WO
0234315 May 2002 WO
0272182 Sep 2002 WO
03090833 Nov 2003 WO
2004032990 Apr 2004 WO
2004105841 Dec 2004 WO
2005018703 Mar 2005 WO
2005037350 Apr 2005 WO
2006037434 Apr 2006 WO
06069380 Jun 2006 WO
2006102676 Sep 2006 WO
2006104806 Oct 2006 WO
2007051563 May 2007 WO
2007056504 May 2007 WO
2008001377 Jan 2008 WO
2008014908 Feb 2008 WO
2008057976 May 2008 WO
2008072229 Jun 2008 WO
2008076459 Jun 2008 WO
2008078318 Jul 2008 WO
2009044401 Apr 2009 WO
2009046989 Apr 2009 WO
2009125398 Oct 2009 WO
2009144085 Dec 2009 WO
2010078227 Jul 2010 WO
2010078242 Jul 2010 WO
2011075105 Jun 2011 WO
2011090955 Jul 2011 WO
2011090956 Jul 2011 WO
2011156373 Dec 2011 WO
2012032411 Mar 2012 WO
2012040528 Mar 2012 WO
2012160157 Nov 2012 WO
2013173092 Nov 2013 WO
2014070453 May 2014 WO
2014179774 Nov 2014 WO
Non-Patent Literature Citations (106)
Entry
Extended European Search Report dated Aug. 7, 2014 in EP Application No. 1417477.4.
Office Action dated Aug. 6, 2014 in EP Application No. 11 707 942.6.
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550069.
Office Action dated Sep. 2, 2014 in JP Application No. 2012-550068.
Office Action dated Aug. 26, 2014 in CN Application No. 201180006567.4.
Int'l Preliminary Report on Patentability dated Oct. 9, 2014 in Int'l Application No. PCT/US2013/033118.
Office Action dated Oct. 9, 2014 in U.S. Appl. No. 13/873,335.
Int'l Search Report dated May 13, 2009 in Int'l Application No. PCT/IL2008/001312.
Int'l Preliminary Report on Patentability dated Apr. 7, 2010 in Int'l Application No. PCT/IL2008/001312; Written Opinion.
Int'l Search Report dated Apr. 26, 2010 in Int'l Application No. PCT/US2009/069552.
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,666.
Office Action dated Sep. 21, 2010 in U.S. Appl. No. 12/244,666.
Office Action dated Apr. 5, 2010 in U.S. Appl. No. 12/244,688.
Office Action dated Sep. 2, 2010 in U.S. Appl. No. 12/244,688.
Office Action dated Sep. 30, 2010 in U.S. Appl. No. 12/689,250.
Int'l Search Report dated Jan. 12, 2011 in Int'l Application No. PCT/US2010/048556; Written Opinion.
International Preliminary Report on Patentability dated Jul. 5, 2011 in International Application No. PCT/US2009/069552; Written Opinion.
Office Action dated Jul. 13, 2011 in U.S. Appl. No. 12/559,563.
Int'l Preliminary Report on Patentability dated Sep. 1, 2011 in Int'l Application No. PCT/US2010/048556.
Office Action dated Sep. 6, 2011 in U.S. Appl. No. 12/345,818.
Office Action dated Feb. 21, 2012 in U.S. Appl. No. 12/689,249.
Int'l Search Report dated Jun. 17, 2011 in Int'l Application No. PCT/US2011/021604.
Int'l Search Report dated Oct. 12, 2011 in Int'l Application No. PCT/US2011/021605.
Office Action dated Oct. 28, 2011 in U.S. Appl. No. 12/615,828.
Int'l Search Report dated Sep. 22, 2011 in Int'l Application No. PCT/IL11/00368; Written Opinion.
U.S. Appl. No. 13/521,181 by Cabiri, filed Jul. 9, 2012.
U.S. Appl. No. 13/521,167 by Cabiri, filed Jul. 9, 2012.
Office Action dated May 16, 2012 in U.S. Appl. No. 12/615,828.
Office Action dated Jul. 2, 2012 in U.S. Appl. No. 13/272,555.
Office Action dated May 3, 2012 in CN Application No. 200880117084.X.
U.S. Appl. No. 13/472,112 by Cabiri, filed May 15, 2012.
U.S. Appl. No. 13/429,840 by Cabiri, filed Mar. 26, 2012.
Int'l Preliminary Report on Patentability dated Aug. 2, 2012 in Int'l Application No. PCT/US2011/021604.
U.S. Appl. No. 13/643,470 by Alon, filed Oct. 25, 2012.
U.S. Appl. No. 13/733,516 by Cabiri, filed Jan. 3, 2013.
U.S. Appl. No. 14/593,051 by Gross, filed Jan. 9, 2015.
Office Action dated Jan. 8, 2013 in JP Application No. 2010-527595.
Int'l Preliminary Report on Patentability dated Feb. 7, 2013 in Int'l Application No. PCT/US2011/021604.
Int'l Preliminary Report on Patentability dated Feb. 7, 2013 in Int'l Application No. PCT/US2011/021605.
English translation of an Office Action dated Jan. 30, 2013 in CN Application No. 200880117084.X.
U.S. Appl. No. 14/193,692 by Gross, filed Feb. 28, 2014.
Office Action dated Feb. 4, 2014 in EP Application No. 11 707 942.6.
English translation of an Office Action dated Mar. 5, 2014 in CN Application No. 200880117084.X.
Int'l Search Report and Written Opinion dated Apr. 3, 2014 in Int'l Application No. PCT/US2013/078040.
Extended European Search Report dated Mar. 27, 2014 in EP Application No. 14154717.4.
Office Action dated Feb. 28, 2014 in CN Application No. 201180006571.0.
U.S. Appl. No. 14/683,193 by Cabiri, filed Apr. 10, 2015.
Office Action dated Feb. 20, 2015 in U.S. Appl. No. 13/521,181 by Cabiri.
Office Action dated Feb. 24, 2015 in U.S. Appl. No. 14/258,661 by Cabiri.
U.S. Appl. No. 14/638,525 by Filman, filed Mar. 4, 2015.
Extended European Search Report dated Feb. 23, 2015 in EP Application No. 14166596.8.
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 13/643,470 by Alon.
Office Action dated Mar. 10, 2015 in U.S. Appl. No. 12/244,666 by Gross.
Extended European Search Report dated Feb. 23, 2015 in EP Application No. 14166591.9.
Office Action dated Mar. 10, 2015 in CN Application No. 201180006567.4.
Office Action dated Mar. 31, 2015 in JP Application No. 2012-550068.
U.S. Appl. No. 13/873,335 by Filman, filed Apr. 30, 2013.
U.S. Appl. No. 13/892,905 by Cabiri, filed May 13, 2013.
U.S. Appl. No. 13/874,121 by Degtiar, filed Apr. 30, 2013.
U.S. Appl. No. 13/874,085 by Cabiri, filed Apr. 30, 2013.
U.S. Appl. No. 13/874,017 by Cabiri, filed Apr. 30, 2013.
U.S. Appl. No. 14/258,661 by Cabiri, filed Apr. 22, 2014.
Int'l Search Report and Written Opinion dated Jan. 7, 2014 in Int'l Application No. PCT/US2013/065211.
Office Action dated May 23, 2014 in U.S. Appl. No. 13/472,112 by Cabiri.
Office Action dated Jun. 3, 2014 in JP Application No. 2010-527595.
Office Action dated Jul. 7, 2014 in U.S. Appl. No. 12/244,666 by Gross.
Int'l Search Report and Written Opinion dated Jul. 31, 2014 in Int'l Application No. PCT/US2014/033598.
Int'l Search Report and Written Opinion dated Jul. 26, 2013 in Int'l Application No. PCT/US2012/039465.
Int'l Search Report and Written Opinion dated Aug. 5, 2013 in Int'l Application No. PCT/US2013/033118.
U.S. Appl. No. 13/964,651 by Gross, filed Aug. 12, 2013.
Office Action dated Aug. 15, 2013 in CN Application No. 200880117084.X.
Office Action dated Nov. 5, 2014 in U.S. Appl. No. 13/643,470 by Alon.
U.S. Appl. No. 14/553,399 by Cabiri, filed Nov. 25, 2014.
Office Action dated Nov. 2, 2014 in CN Application No. 201180006571.0.
Office Action dated Nov. 21, 2014 in U.S. Appl. No. 13/472,112 by Cabiri.
Office Action dated Nov. 21, 2014 in U.S. Appl. No. 13/429,840 by Cabiri.
Int'l Preliminary Report on Patentability dated Nov. 27, 2014 in Int'l Application No. PCT/US2013/039465.
Office Action dated Oct. 9, 2013 in IL Application No. 208634.
Office Action dated Nov. 5, 2013 in JP Application No. 2010-527595.
Office Action dated Sep. 29, 2013 in CN Application No. 201080040968.7.
Office Action dated Nov. 4, 2013 in EP Application No. 11 709 234.6.
Office Action dated Dec. 17, 2013 in JP Application No. 2012-529808.
Office Action dated Dec. 10, 2013 in CN Application No. 201180006567.4.
Office Action dated Jan. 8, 2014 in U.S. Appl. No. 13/521,167 by Cabiri.
U.S. Appl. No. 29/479,307 by Norton, filed Jan. 14, 2014.
Office Action dated Jul. 31, 2015 in U.S. Appl. No. 13/521,181 by Cabiri.
Office Action dated Aug. 13, 2015 in U.S. Appl. No. 14/553,399 by Cabiri.
Notice of Allowance dated Aug. 24, 2015 in U.S. Appl. No. 29/479,307 by Norton.
Daikyo Crystal Zenith® polymer, Manufactured by Daikyo Seiko, Ltd. (Jun. 25, 2008).
Copaxone®, Manufactured by Teva Pharmaceutical Industries Ltd. (2009).
Int'l Preliminary Report on Patentability dated May 14, 2015 in Int'l Application No. PCT/US2013/065211.
Office Action dated May 7, 2015 in JP Application No. 2012-550069.
Office Action dated May 13, 2015 in CN Application No. 201380025566.3.
U.S. Appl. No. 14/715,791 by Cabiri, filed May 19, 2015.
U.S. Appl. No. 14/725,009 by Bar-El, filed May 29, 2015.
Office Action dated May 1, 2015 in U.S. Appl. No. 14/638,525 by Filman.
Office Action dated Jan. 15, 2016 in U.S. Appl. No. 13/472,112 by Cabiri.
Office Action dated Sep. 9, 2015 in U.S. Appl. No. 13/643,470 by Alon.
U.S. Appl. No. 14/850,450 by Gross, filed Sep. 10, 2015.
U.S. Appl. No. 14/861,478 by Cabiri, filed Sep. 22, 2015.
U.S. Appl. No. 14/880,673 by Cabiri, filed Oct. 12, 2015.
Office Action dated Sep. 18, 2015 in U.S. Appl. No. 13/874,085 by Cabiri.
Office Action dated May 24, 2017 in CN Application No. 2013800571961.
Office Action dated Nov. 2, 2016 in CN Application No. 2013800571961.
Search Report dated Nov. 2, 2016 in CN Application No. 2013800571961.
Office Action dated Sep. 13, 2017 in EP Application No. 13783458.6.
Related Publications (1)
Number Date Country
20140128815 A1 May 2014 US